Role of insulin on jejunal pept1 expression and function regulation in diabetic male and female rats

Canadian Journal of Physiology and Pharmacology

Volumn 88, Issue 7, 2010, Pages 753-759

  Der Boghossian, Asdghig H ^a   Saad, Sara R ^a   Perreault, Claudine ^b   Provost, Chantale ^b   Jacques, Danielle ^b   Kadi, Lina N ^a   Issa, Nahla G ^a   Sibai, Abla M ^a   El Majzoub, Nadim W ^a   Bikhazi, Anwar B ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Insulin; Intestinal symporter; PepT1 function; PepT1 gene expression; Regulatory pathways; Sex; Type 1 diabetes

Indexed keywords

BOVINE INSULIN; GLUCOSE; GLYCYLSARCOSINE; MESSENGER RNA; PEPTIDE TRANSPORTER 1; COTRANSPORTER; DIPEPTIDE; ESTROGEN; INSULIN; PRIMER DNA; SLC15A1 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HORMONE ACTION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEX DIFFERENCE; STREPTOZOCIN DIABETES; ANIMAL; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GENETICS; JEJUNUM; METABOLISM; NUCLEOTIDE SEQUENCE; SEXUAL DEVELOPMENT; SPRAGUE DAWLEY RAT;

ANIMALS; BASE SEQUENCE; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIPEPTIDES; DNA PRIMERS; ESTROGENS; FEMALE; GENE EXPRESSION; INSULIN; JEJUNUM; MALE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEX CHARACTERISTICS; SYMPORTERS;

EID: 78049487416     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y10-037     Document Type: Article

References (25)

1. Bevan, P. 2001. Insulin signalling. J. Cell Sci. 114(Pt 8): 1429-1430.PMID:11282018.
2. Bikhazi, A.B., Skoury, M.M., Zwainy, D.S., Jurjus, A.R., Krey-diyyeh, S.I., Smith, D.E., et al. 2004. Effect of diabetes mellitus and insulin on the regulation of the PepT 1 symporter in rat je-junum, Mol.Pharm. 1(4): 300-308. doi:10.1021/mp049972u.PMID:15981589.
3. 2+ channel in aortic smooth muscle cells via a pertussis toxin and cholera toxin sensitive G-protein, Mol.Cell.Biochem. 183(1-2): 39-47. doi:10.1023/A:1006887714302. PMID:9655176.
4. Dabelea, D., Kinney, G., Snell-Bergeon, J.K., Hokanson, J.E., Eckel, R.H., Ehrlich, J., et al.; Coronary Artery Calcification in Type 1 Diabetes Study. 2003. Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes, 52(11):2833-2839 doi:10. 2337/diabetes.52.11.2833. PMID:14578303.
5. Herrera-Ruiz, D., and Knipp, G.T. 2003. Current perspectives on established and putative mammalian oligopeptide transporters. J. Pharm. Sci. 92(4): 691-714. doi:10.1002/jps.10303. PMID:12661057.
6. Hussain, I., Kellett, L., Affleck, J., Shepherd, J., and Boyd, R. 2002. Expression and cellular distribution during development of the peptide transporter (PepT1) in the small intestinal epithelium of the rat. Cell Tissue Res. 307(1): 139-142. doi:10.1007/ s00441-001-0473-z. PMID:11810321.
7. Kellett, G.L., and Brot-Laroche, E. 2005. Apical GLUT2: a major pathway of intestinal sugar absorption. Diabetes, 54(10): 3056-3062. doi:10.2337/diabetes.54.10.3056. PMID:16186415.
8. Lee, V.H. 2001. Mucosal drug delivery. J. Natl. Cancer Inst.Monogr. 29(29): 41-44.PMID:11694565.
9. Legato, M.J., Gelzer, A., Goland, R., Ebner, S.A., Rajan, S., Villagra, V., and Kosowski, M.Writing Group for The Partnership for Gender-Specific Medicine. 2006. Gender-specific care of the patient with diabetes: review and recommendations. Gend. Med. 3(2): 131-158. doi:10.1016/S1550-8579(06)80202-0. PMID:16860272.
10. +/peptide co transporter: cloning, functional expression, and chromosomal localization. J. Biol. Chem. 270(12): 6456-6463.PMID:7896779.
11. McConnell, K.J., Zadvorny, E.B., Denham, A.M., Kasten, S.L., Hutka, K.A., Koetting, C.R., and Merenich, J.A.; Clinical Pharmacy Cardiac Risk Service Study Group. 2007. Angiotensin-converting enzyme inhibitor therapy for coronary artery disease and diabetes mellitus. Am. J. Manag. Care, 13(10): 560-566.PMID:17927460.
12. Miyamoto, K., Shiraga, T., Morita, K., Yamamoto, H., Haga, H., Taketani, Y., et al. 1996. Sequence, tissue distribution and developmental changes in rat intestinal oligopeptide transporter. Biochim. Biophys. Acta, 1305(1-2): 34-38. PMID:8605246.
13. Murphy, M.J., Metcalf, B.S., Voss, L.D., Jeffery, A.N., Kirkby, J., Mallam, K.M., and Wilkin, T.J.; EarlyBird Study (EarlyBird 6). 2004. Girls at five are intrinsically more insulin resistant than boys: the programming hypotheses revisited-The EarlyBird Study (EarlyBird 6). Pediatrics, 113(1 Pt 1): 82-86. doi:10.1542/peds.113.1.82. PMID:14702453.
14. Naidoo, D.P. 2002. The link between microalbuminuria, endothe-lial dysfunction and cardiovascular disease in diabetes. Cardio-vasc. J. S. Afr. 13(4): 194-199.PMID:12389063.
15. Nakanishi, T., Tamai, I., Takaki, A., and Tsuji, A. 2000. Cancer cell-targeted drug delivery utilizing oligopeptide transport activity. Int. J. Cancer, 88(2): 274-280.doi:10.1002/1097-0215(20001015)88:2<274::AID-IJC20>3.0.CO; 2-5. PMID:11004680.
16. Nielsen, C.U., and Brodin, B. 2003. Di/tri-peptide transporters as drug delivery targets: regulation of transport under physiological and patho-physiological conditions. Curr. Drug Targets, 4(5):373-388. doi:10.2174/1389450033491028. PMID:12816347.
17. +/peptide cotran-sporter in rat digestive tract. Biochem.Biophys.Res.Commun. 220(3): 848-852. doi:10.1006/bbrc.1996.0493. PMID:8607854.
18. Saito, H., Terada, T., Okuda, M., Sasaki, S., and Inui, K. 1996. Molecular cloning and tissue distribution of rat peptide transporter PEPT2. Biochim. Biophys. Acta, 1280(2): 173-177. doi:10. 1016/0005-2736(96)00024-7. PMID:8639691.
19. Shen, H., Smith, D.E., and Brosius, F.C., 3rd. 2001. Development expression of PepT1 and PepT2 in rat small intestine, colon and kidney. Pediatr.Res. 49(6): 789-795. doi:10.1203/00006450-200106000-00013.
20. +/peptide transporter PepT1. Gastroenterology, 116(2): 354-362. doi:10.1016/S0016-5085(99)70132-0. PMID:9922316.
21. Szymborska-Kajanek, A., Wrobel, M., Grzeszczak, W., and Strojek, K. 2007. Inhaled insulin: the breakthrough in the treatment of diabetes? Pol. Arch. Med. Wewn. 117(9): 415-419.PMID: 18062564.
22. Thamotharan, M., Bawani, S.Z., Zhou, X., and Adibi, S.A. 1999. Hormonal regulation of oligopeptide transporter pept-1 in a human intestinal cell line. Am. J. Physiol. 276(4 Pt 1): C821-C826.PMID:10199812.
23. Urtti, A., Johns, S.J., and Sadée, W. 2001. Genomic structure of proton-coupled oligopeptide transporter hPEPT1 and pH-sensing regu-latory splice variant. AAPS PharmSci, 3(1): E6.PMID:11741257.
24. Yang, C.Y., Dantzig, A.H., and Pidgeon, C. 1999. Intestinal peptide transport systems and oral drug availability. Pharm. Res. 16(9): 1331-1343. doi:10.1023/A:1018982505021. PMID:10496647.
25. Zandbergen, A.A., Sijbrands, E.J., Lamberts, S.W., and Bootsma, A.H. 2006. Normotensive women with type 2 diabetes and micro-albuminuria are at high risk for macrovascular disease. Diabetes Care, 29(8): 1851-1855. doi:10.2337/dc06-0287. PMID:16873791.